Graphic Information Presentation System (GIPSY) Users Manual

1991 ◽  
Author(s):  
Jeanne L. Muenzen
Keyword(s):  
Information Presentation ◽  
Graphic Information

On information presentation via dual kinesthetic-tactual displays

1974 ◽  
Author(s):  
Robert E. Fenton ◽  
Richard D. Gilson ◽  
Ronald W. Ventola
Keyword(s):  
Information Presentation

The Interaction Between Semantic and Graphic Information During Prerecognition Visual Processing

1994 ◽  
Author(s):  
Lloyd L. Avant ◽  
James Stamper ◽  
Robert Such ◽  
Alice A. Thieman
Keyword(s):  
Visual Processing ◽  
Graphic Information

To See or Not to See

2021 ◽  
Vol 5 (1) ◽  
pp. 1-25
Author(s):  
Linda Hirsch ◽  
Christina Schneegass ◽  
Robin Welsch ◽  
Andreas Butz
Keyword(s):  
Digital Library ◽  
Inattentional Blindness ◽  
Design Strategies ◽  
Information Presentation ◽  
Literature Study ◽  
Public Places ◽  
Public Square ◽  
User Intentions

People visit public places with different intentions and motivations. While some explore it carefully, others may just want to pass or are otherwise engaged. We investigate how to exploit the inattentional blindness (IB) of indirect users in the design of public interfaces to apply to such diverse needs. Beginning with a structured literature study in the ACM Digital Library on IB, we analyzed 135 publications to derive design strategies that benefit from IB or avoid IB. Using these findings, we selected three existing interfaces for information presentation on a large public square and created two additional interfaces ourselves. We then compared users' perceptions through a self-reported photography study (N = 40). Participants followed one of four scripted profiles to imitate different user intentions, two for direct and two for indirect users. We hypothesized that direct users would recognize the interfaces, while indirect users would experience IB and ignore them. Our results show that direct users reported up to 68% of our interfaces, whereas indirect users noticed only 16%. Thus, IB can be exploited to hide interfaces from indirect users while keeping them noticeable to direct users.

Digital printing technology and its application in packaging printing

2021 ◽  
pp. 002072092199660
Author(s):  
Bo Peng
Keyword(s):  
Economic Development ◽  
Publishing Industry ◽  
Development Trend ◽  
Digital Printing ◽  
Printing Technology ◽  
The Core ◽  
Technical Content ◽  
Graphic Information ◽  
Challenges And Opportunities ◽  
Printing Machine

Today, with the increasingly rapid economic development and diversified consumer demands, the printing and publishing industry is also facing challenges and opportunities. Under this background, the emerging digital printing technology, which USES modern digital system to transmit graphic information to digital printing machine through network, has gradually become the core technical content of the printing field. Based on the emergence and characteristics of digital printing, this paper focuses on the application of digital printing technology in packaging printing, and predicts the future development trend of digital printing technology, hoping to help readers understand the knowledge of digital printing technology.

scholarly journals SAT0636-HPR PATIENT EXPERIENCE WITH THE PRESCRIPTION, INFORMATION AND USE OF METHOTREXATE

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1277.3-1278
Author(s):  
T. Oton ◽  
L. Carmona ◽  
J. L. Andréu Sánchez
Keyword(s):  
Side Effects ◽  
Focus Groups ◽  
Rheumatic Diseases ◽  
Lupus Erythematosus ◽  
Physical Symptoms ◽  
Number Of Factors ◽  
Graphic Information ◽  
Main Barrier ◽  
And Training

Background:Methotrexate (MTX) is currently a mainstream drug in the treatment of rheumatic diseases. However, the response to MTX is not universal and may be conditioned by a number of factors, among which adherence could be crucial.Objectives:The aim of this study is to explore adherence to MTX in patients with rheumatic diseases, facilitators and perceived when taking and maintaining the prescription.Methods:A qualitative study of content analysis was performed. Focus groups with patients taking either oral or subcutaneous MTX (being the main or coadjuvant treatment) for any rheumatic disease was performed. The groups were moderated by a rheumatologist that was unknown for the patients. The speech was recorded and transcribed. Subsequently, an inductive coding was performed with the help of Atlas.ti and main themes and sub-themes were extracted, with examples of verbatim anonymized speech.Results:Three focus groups were conducted, with a total of 12 participants, of whom eight were women, seven had rheumatoid arthritis, three had psoriatic arthritis, one had spondyloarthritis, and one had systemic lupus erythematosus. All patients reported an adequate adherence to treatment. The barriers identified were: information in the leaflet, technical language in the consults, difficult access to doctor´s appointment, social environment, side effects and the subcutaneous device. As facilitators, the following aspects were discussed: good predisposition of the physician, reliable graphic information, role of associations and partners support.The unmet needs detected were: problems with travelling, protocols for eventualities, absence of a plan of care, neglection of “non-physical” symptoms, disinformation on side effects and training in complementary aspects.Conclusion:Getting reliable information was the main barrier identified. The environment and side effects may also negatively impact on adherence. Shared decision making is a goal to be achieved in the future in these patients.Disclosure of Interests:Teresa Oton Consultant of: Novartis Farmaceutica, SA, Pfizer, S.L.U., Merck Sharp & Dohme España, S.A., Roche Farma, S.A, Sanofi Aventis, AbbVie Spain, S.L.U., and Laboratorios Gebro Pharma, SA (All trhough institution), Loreto Carmona Grant/research support from: Novartis Farmaceutica, SA, Pfizer, S.L.U., Merck Sharp & Dohme España, S.A., Roche Farma, S.A, Sanofi Aventis, AbbVie Spain, S.L.U., and Laboratorios Gebro Pharma, SA (All trhough institution), José Luis Andréu Sánchez: None declared

Sign in / Sign up

Export Citation Format

Share Document